[HTML][HTML] Targeting the CD27-CD70 pathway to improve outcomes in both checkpoint immunotherapy and allogeneic hematopoietic cell transplantation
Immune checkpoint inhibitor therapies and allogeneic hematopoietic cell transplant
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …
Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation.
F Lutfi, L Wu, S Sunshine, X Cao - Frontiers in Immunology, 2021 - europepmc.org
Immune checkpoint inhibitor therapies and allogeneic hematopoietic cell transplant
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …
Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation
F Lutfi, L Wu, S Sunshine… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitor therapies and allogeneic hematopoietic cell transplant
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …
Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation
F Lutfi, L Wu, S Sunshine, X Cao - Interferons and graft-versus …, 2023 - books.google.com
Immune checkpoint inhibitor therapies and allogeneic hematopoietic cell transplant
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …
[HTML][HTML] Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation
F Lutfi, L Wu, S Sunshine, X Cao - Frontiers in Immunology, 2021 - ncbi.nlm.nih.gov
Immune checkpoint inhibitor therapies and allogeneic hematopoietic cell transplant
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …